Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay

Atsushi Ishida(Maruyama Memorial General Hospital), Shozo Yamada(Memorial Hospital of South Bend), Naoko Inoshita(Toranomon Hospital), Wataru Ogawa(Kobe University), Hiroki Shichi(Kobe University), Hidenori Fukuoka(Kobe University Hospital)
Pituitary
November 13, 2021
Cited by 18


Related Papers